OTC:RGBP | Operating Income | Regen BioPharma Inc

Complete source-backed operating income history.

Available history
2013-03-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30$24,528.00
2026-03-31-$153,709.00
2025-12-31-$551,624.00
2025-09-30-$123,055.00
2025-06-30-$40,756.00
2025-03-31-$113,349.00
2024-12-31-$61,378.00
2024-09-30-$85,402.00
2024-06-30-$107,966.00
2024-03-31-$101,071.00
2023-12-31-$122,782.00
2023-09-30-$59,087.00
2023-06-30-$85,155.00
2023-03-31-$78,842.00
2022-12-31-$463,867.00
2022-09-30-$97,779.00
2022-06-30-$58,910.00
2022-03-31-$76,494.00
2021-12-31-$106,422.00
2021-09-30-$126,826.00
2021-06-30-$42,491.00
2021-03-31-$12,973.00
2020-12-31-$18,480.00
2020-09-30-$18,909.00
2020-06-30-$16,336.00
2020-03-31-$39,334.00
2019-12-31-$134,738.00
2019-09-30-$189,438.00
2019-06-30-$137,720.00
2019-03-31-$230,793.00
2018-12-31-$198,834.00
2018-09-30-$263,292.00
2018-06-30-$125,234.00
2018-03-31-$447,672.00
2017-12-31-$879,585.00
2017-09-30-$780,096.00
2017-06-30-$553,052.00
2017-03-31-$659,157.00
2016-12-31-$533,580.00
2016-09-30-$676,850.00
2016-06-30-$870,782.00
2016-03-31-$719,879.00
2015-12-31-$689,452.00
2015-09-30-$523,037.00
2015-06-30-$621,410.00
2015-03-31-$621,418.00
2014-12-31-$213,409.00
2014-09-30-$192,609.00
2014-06-30-$157,867.00
2014-03-31-$170,043.00
2013-12-31-$185,835.00
2013-06-30-$74,829.00
2013-03-31-$70,505.00

Annual Operating Income

DateOperating Income
2025-09-30-$338,540.00
2024-09-30-$417,221.00
2023-09-30-$686,950.00
2022-09-30-$339,605.00
2021-09-30-$200,771.00
2020-09-30-$209,317.00
2019-09-30-$756,785.00
2018-09-30-$1.43M
2017-09-30-$2.51M
2016-09-30-$2.96M
2015-09-30-$1.98M
2014-09-30-$706,354.00
2013-09-30-$319,836.00